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This mini-review summarizes techniques applied in, and results obtained with, proteomic
studies of human immunodeﬁciency virus type 1 (HIV-1)–T cell interaction. Our group pre-
viously reported on the use of two-dimensional differential gel electrophoresis (2D-DIGE)
coupled to matrix assisted laser-desorption time of ﬂight peptide mass ﬁngerprint analysis,
to study T cell responses upon HIV-1 infection. Only one in three differentially expressed
proteins could be identiﬁed using this experimental setup. Here we report on our latest
efforts to test models generated by this data set and extend its analysis by using novel
bioinformatic algorithms.The 2D-DIGE results are compared with other studies including a
pilot study using one-dimensional peptide separation coupled to MSE, a novel mass spec-
trometric approach. It can be concluded that although the latter method detects fewer
proteins, it is much faster and less labor intensive. Last but not least, recent developments
and remaining challenges in the ﬁeld of proteomic studies of HIV-1 infection and proteomics
in general are discussed.
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INTRODUCTION
Human immunodeﬁciency virus type 1 (HIV-1), the causative
agent of AIDS, uses CD4+ T cells as a host. In order to do so
efﬁciently the virus adapts the host cell’s intracellular metabolism.
The host cell, in turn, initiates intracellular antiviral responses
and signals to the host’s immune system (Lever and Jeang, 2011).
Thus, HIV-1 infection and the host response trigger many phys-
iological changes in the infected cell (Gomez and Hope, 2005).
HIV-1 survives and persists in infected cells preparing them for
production and release of new viral particles. Intracellular changes
due to HIV-1 infection have been studied extensively, focusing
on the contribution of HIV-1’s accessory proteins to these pro-
cesses, using microarrays or serial analysis of gene expression
(SAGE) to detect mRNA changes in the cell (Van’t Wout et al.,
2003; Giri et al., 2006; Roeth and Collins, 2006; Lefebvre et al.,
2011; Wu et al., 2011). Gene expression proﬁling with microar-
rays is of course easy to perform, generating large datasets quickly
(Heller, 2002), but sequences must be known in advance, which
SAGE does not require. SAGE, based on direct sequencing of
mRNA tags, also does not use hybridization as microarrays do,
leading to more reliable probing of mRNA levels. SAGE is cur-
rently being replaced by high-throughput sequencing technologies
(RNA-Seq; Baginsky et al., 2010). Proteome changes upon HIV
infection have also been studied in detail with mass spectrom-
etry (Coiras et al., 2006; Chan et al., 2007; Ringrose et al., 2008;
Navare et al., 2012), lately focusing on studies speciﬁcally mon-
itoring direct interactions between viral and cellular proteins
(Jager et al., 2012a,b).
Changes in gene expression patterns characterize the cellular
response to HIV-1 infection. However, changes in mRNA levels
are only part of the story. Often stringent correlation between
mRNA and protein levels is lacking (Pradet-Balade et al., 2001).
In human cells, transcription seems to explain only 30% of vari-
ation in protein levels, with translation and protein degradation
contributing up to 40% (Vogel et al., 2010; Schwanhausser et al.,
2011). In E. coli, relative contributions to regulation of pro-
tein levels via transcriptional and/or translational control have
even been shown to vary greatly with the kind of signal the
cell responds to (Kramer et al., 2010). Direct cellular responses
are also strongly accompanied by coordinated protein modiﬁca-
tions. A protein can exist in many different isoforms, each with
its own speciﬁc function, with a relatively limited number of
genes giving rise to vast amounts of (functionally) distinct proteins
(Jensen, 2006). This is mostly accomplished by post-translational
protein modiﬁcation (PTM). PTMs constitute highly versatile
systems allowing cells to respond very quickly to both external
and internal signals, as illustrated by protein phosphorylation
in signal transduction or metabolic regulation. Of course, such
PTM responses cannot be detected using DNA/RNA sequencing
technologies. Thus, proteomic studies using mass spectrometry
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to detect and quantify differences in protein expression, pro-
tein isoforms and complexes, as well as PTMs, are essential for
understanding the complete set of intracellular responses to HIV-
1 infection. In this way new insights and intervention strategies
can be developed.
In a previous study, we used the ﬂuorescence two-dimensional
differential gel electrophoresis (2D-DIGE) technique for a com-
parison of uninfected and HIV-1 infected T cells (Ringrose et al.,
2008). This technique starts out with minimal protein labeling
using cyanine based ﬂuorescent probes recognizing lysine. A sub-
sequent two-dimensional gel electrophoresis allows the quantiﬁ-
cation of changes in protein expression by mixing cell extracts
labeled either with Cy3 or Cy5 and running them on a single gel
(Unlu et al., 1997; Alban et al., 2003). Next, differentially expressed
proteins can be identiﬁed by peptide mass ﬁngerprinting (PMF)
using a matrix assisted laser-desorption time of ﬂight (MALDI-
TOF) mass spectrometer. PMF uses lists of masses of peptides
(“ﬁngerprints”) generated by tryptic digestion of proteins for
their identiﬁcation. NB: In this approach quantiﬁcation is based
on amount of ﬂuorescence and not on ion detection level in a
mass spectrometer. The study conﬁrmed several HIV-1 effects
on pathways and cellular processes previously described using
stable isotope labeling combined with liquid chromatography–
mass spectrometry (LC–MS; Chan et al., 2007). But there were
novel ﬁndings as well, most importantly the downregulation of
proteins involved in glycolysis upon full-blown HIV-1 infection,
presumably part of a complete metabolic rerouting to preserve
glucose for the pentose phosphate pathway, the source of riboses
for subsequent viral nucleic acid synthesis (Ringrose et al., 2008).
However, despite the success of this 2D-DIGE PMF approach it
also comes with some limitations: the technique is very labor
intensive and about two-thirds of all the differentially expressed
proteins detected could not be identiﬁed using PMF because they
were not present in sufﬁcient abundance. As we are planning
to extend our proteomic analysis of HIV-1 T cell interaction to
subcellular fractions, a faster method would be preferable. To
that end we compared the 2D-DIGE PMF with one-dimensional
separation of peptides using reversed phase LC coupled to MSE
(Geromanos et al., 2009) analysis, again using T cells infected with
HIV-1. In this approach target proteins are digested with trypsin
(as in the PMF method mentioned above), and resulting pep-
tides (parent ions in Figure 1) are now identiﬁed as coming from
certain proteins by the mass analysis of their fragments (daugh-
ter ions in Figure 1), which allows peptide sequencing [in both
data-dependent modes of acquisition (DDA) and MSE applica-
tions described below] as well as protein quantitation by peptide
signal abundance.
A PILOT STUDY USING LC–MSE
One of the most exciting new developments in proteomic analy-
ses is the possibility to perform quantitative protein comparisons
without having to introduce quantiﬁable labels: label-free pro-
teomics. Here we report on the use of label-free proteomics
in a pilot study of T cells (PM1 T cell line) infected with
HIV-1 (LAI isolate). In this setup a novel data-independent alter-
nate scanning technique (MSE) on a quadrupole time of ﬂight
(QTOF) instrument is used. In contrast to DDA, making up
the standard method on various types of instruments used in
peptide based proteomics, MSE does not select a single pre-
cursor ion for fragmentation but rather fragments “all” ions
present at any given time during chromatographic separation.
As such, mass spectrometric data are collected (in principle) on
fragments of “all” ions instead of a subset that is selected for
fragmentation during DDA analysis. This decreases bias toward
selecting only highly abundant peptides and eliminates the need
to measure samples multiple times in order to collect tandem-MS
data for “all” ions present (Figure 1). In this manner, MSE
greatly expands the number of peptides detected using limited
LC-separation compared to DDA on QTOF type instruments
(Geromanos et al., 2009).
A drawback of MSE is its incompatibility with quantitation
schemes that make use of an amine reactive isotopic-label and
speciﬁc reporter fragment ions to ascertain protein quantity such
as iTRAQ (isobaric tag for relative and absolute quantiﬁcation;
Wiese et al., 2007). This approach was used very recently for quan-
titation of early effects of HIV infection (Navare et al., 2012) using
multi-dimensional separation and an Orbitrap mass spectrome-
ter (Makarov and Scigelova, 2010) in which 1448 proteins were
reliably quantiﬁed. However, LC–MSE is well suited for label-free
quantitation and pilot studies applying it to our model system
(uninfected PM1 T cells vs. cells at the peak of HIV-1 infec-
tion) are promising. So far we could quantify 358 proteins, with
at least 16 proteins clearly up- or downregulated (more than
twofold). Six enzymes involved in glycolysis were identiﬁed. Con-
sistent with our previous observations these were found either
to be hardly changed or downregulated. Several other proteins
found to be changed in abundance previously (Ringrose et al.,
2008) were again detected, but whereas, e.g. Stathmin (Q96CE4)
is downregulated as before, several 14-3-3 proteins are now upreg-
ulated instead of downregulated (see Discussion). Total numbers
of identiﬁed proteins are obviously lower than in the 2D-DIGE
approach, but the technique is much faster, and less labor inten-
sive (days vs. months). Also, as lower amounts of protein are
needed for analysis, smaller and more reproducible cell cul-
ture samples can be used. In the future we plan to combine
this approach with in-line enrichment of phosphopeptides using
titanium dioxide chromatography (Pinkse et al., 2004, 2011) to
look at changes in the cellular phosphoproteome upon HIV-1
infection. In addition, LC–MSE will be used with cell lines con-
taining an inducible HIV-1 provirus (Jeeninga et al., 2008). This
allows a more synchronous induction of virus production com-
pared to viral infection, increasing the sensitivity of the assay
such that small biological changes can be detected. This will
also make it feasible to discriminate between changes induced by
the initial virus infection and the subsequent stage of new virus
production.
FOLLOW-UP RESEARCH USING RNAi-MEDIATED
KNOCKDOWN OF CELL FACTORS
Follow-up study on some of the proteins identiﬁed in the 2D-
DIGE study was performed with an RNA interference (RNAi)
knockdown screen. Protein induction may reﬂect host defensive
mechanisms to prevent or restrict virus infection or replication.
Alternatively, such changesmay represent a viral strategy to induce
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FIGURE 1 | An overview of LC–MSE. Separation of peptides (colored dots)
on an LC coupled to a QTOF instrument in a data-independent mode of
acquisition using electrospray ionization (A). In a data-independent mode of
acquisition the quadrupole (MS1) continuously allows passage of all ions, in
contrast to DDA where the quadrupole selects ions for fragmentation based
on their intensity. Energy in the collision cell is continuously cycled between a
low and an elevated proﬁle. This generates spectra of all parent (B) and
daughter ions (D) throughout the LC–MS run in the time of ﬂight analyzer
(MS2) without bias with respect to their relative intensities. In order to
reconstruct fragment ion spectra with daughter ions from a single parent
only, an ion-accounting algorithm compares the retention time proﬁles of all
individual parent ions (C) to all individual daughter ions (E) matching them on
the basis of retention time proﬁle and intensity (G). In this manner the
algorithm creates a reconstructed daughter ion spectrum matched to a single
precursor (F) that can be used by proteome search engines to identify
peptides and link these to proteins. The unbiased data-independent scanning
mode greatly expands the number of peptides – and thus of proteins –
detected, compared to the DDA mode of acquisition on QTOF type
instruments, especially using limited LC separations on complex mixtures to
increase throughput. Adapted from (Plumb et al., 2006).
cellular factors facilitating speciﬁc steps of the replication cycle
(cofactors). For 76 cellular targets the impact on HIV-1 replica-
tion was studied upon mRNA knockdown, using short hairpin
RNA (shRNA) inhibitors from the MissionTM library (Moffat
et al., 2006). For each target gene four to ﬁve shRNAs to gener-
ate stably transduced T cells were used, thus reducing the chance
of scoring off-target effects. Knockdown of 38 individual mRNA
targets resulted in decreased virus replication, possibly because
of suppression of a viral cofactor. Of these, 27 proteins were
upregulated during HIV-1 infection in our previous 2D-DIGE
proteomic screen, ﬁtting the cofactor role. For three targets an
increase in viral replication was observed, raising the possibility
that a viral restriction factor was hit (unpublished results).
BIOINFORMATIC ANALYSIS OF 2D-DIGE DATA
As mentioned above, one of the most severe limitations of the
2D-DIGE PMF approach lies in the fact that about two-thirds
of all the differentially expressed proteins detected cannot be
identiﬁed using PMF, as they are not sufﬁciently abundant. This
reﬂects the major challenge in all proteomic studies: identiﬁcation
and (relative) quantiﬁcation of proteins with lower abundancies.
We detected 1920 spots, of which 15% (288) were differentially
expressed at 7–10 days post-infection (p.i.; Ringrose et al., 2008).
Of these 288 differentially expressed protein spots, 182 remain
to be identiﬁed. However, we have some additional informa-
tion regarding these unidentiﬁed protein spots: we know the pI
and Mw of the protein, i.e. of the speciﬁc isoform(s) detected,
which in most cases represent the most abundant, mature pro-
tein form(s). We can also surmise what pathways the proteins
most likely are involved in, based on the results obtained for the
∼100 identiﬁed spots. Using this information we are develop-
ing bioinformatic algorithms to come up with accurate lists of
candidate differentially expressed proteins upon virus infection.
Obviously, such candidates have to be conﬁrmed experimentally,
checked for instancewith highly sensitive antibody-basedmethods
such as western blotting. We developed a prioritization approach
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FIGURE 2 | How to identify candidate proteins based on pI and Mw. For details see text.
consisting of ﬁve steps (Figure 2). First, for the PMF-identiﬁed
proteins the theoretical pI and Mw are computed for the mature
form using “Compute pI/Mw”1. Second, two non-linear mod-
els are ﬁtted to predict pI and Mw, respectively. Parameters of
the model are estimated from the x/y-coordinates of the identi-
ﬁed spots and the pI and Mw determined in the previous step.
Next, we use these models to predict pI and Mw for unidenti-
ﬁed spots. Third, for each unidentiﬁed spot a list of candidate
proteins is determined using the estimated pI and Mw as input
for TagIdent2. TagIdent requires specifying a window size for the
estimated pI and Mw. Because of uncertainty in the pI and Mw
values, we choose relatively large windows so that the candidate
list is likely to include the correct protein. However, candidate
lists thus often contain hundreds of proteins. This is addressed
in the last two steps, using the principle of “guilt by association”:
more likely candidate proteins share more features with already
identiﬁed proteins, e.g., being present in the same pathway. In
the fourth step of our algorithm the physical and/or functional
interactions of the ∼100 identiﬁed proteins are extracted from
the Search Tool for the Retrieval of Interacting Genes (STRING)
database (Szklarczyk et al., 2011). STRING covers co-occurrence
in pathways, physical protein–protein interactions, co-occurrence
in the abstracts of scientiﬁc reports, etc., and provides conﬁdence
scores for strengths of the associations. In step 5, candidate pro-
teins are ranked using conﬁdence scores by summing weighted
1http://web.expasy.org/compute_pi/
2http://web.expasy.org/tagident/
interactions with our“identiﬁed protein”STRING set. By combin-
ing 2D-DIGE with this kind of bioinformatic algorithm it would
become one of the ﬁrst techniques able to identify differential
proteins in the lower regions of the dynamic range.
DISCUSSION
Comparing proteomic studies that address HIV–T cell interac-
tion, it is observed that the various approaches yield a wide range
in reported numbers of quantiﬁable proteins, ranging from 3255
(Chan et al., 2007) and 1448 (Navare et al., 2012) in total quantiﬁ-
able proteins for techniquesusingmulti-dimensional separationof
peptides to 92 differentially expressed proteins (out of 1,920 spots)
in a 2D-DIGE approach (Ringrose et al., 2008). In contrast, the
numbers of differentially expressed proteins are somewhat com-
parable at various times p.i. Ringrose et al. (2008) reported 9 (42 h
p.i.) and 92 (7–10 days p.i.) regulated proteins upon infection,
while the group of Katze detected 687 (36 h p.i.) changed proteins
(Chan et al., 2007) and found 266 (4 h p.i.), 60 (8 h p.i.), and
22 (20 h p.i.) proteins differentially expressed earlier on in infec-
tion (Navare et al., 2012). Although numbers can of course vary
according to statistical signiﬁcance settings, only a small subset of
proteins is usually identiﬁed by all methods (Fahey et al., 2011).
Each experimental setup yields a considerable group of proteins
that are not scored by the other methods. This complementarity
can be explained not only by differences in detection and quantiﬁ-
cation methods, but frequently by differences in the experimental
biological systems as well. Variations include: host cell type and
virus isolate (e.g., with a different receptor use and cell tropism),
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and timepoint of sampling. Especially the impact of this latter vari-
able should not be underestimated. It can even determine whether
differentially expressed protein(form)s are found to be up- or
downregulated in the interaction between HIV-1 and its host. 14-
3-3 protein epsilon (P62258) is a case in point: it is upregulated
after 4 h p.i. and downregulated later on at 7–10 days p.i. (Ringrose
et al., 2008). Three other 14-3-3 proteins now seem to follow suit:
tau/theta (P27348), gamma (P61981), and zeta/delta (P63104)
are found to be upregulated in our latest MSE experiments, but
were clearly found to be downregulated in (Ringrose et al., 2008).
These proteins can be phosphorylated on serine as well as thre-
onine, e.g., inﬂuencing their migration on 2D, and consequently
pattern and abundance changes can be difﬁcult to interpret. As
mentioned, an interesting recent study to look at the earliest events
in HIV infection characterizing the host response at the protein
level in CD4+ SUP-T1 cells 4, 8, and 20 h p.i. using HIV-1 strain
LAI, was performed by Navare et al. (2012). Comparison of this
study to Ringrose et al. (2008), again shows the virus–cell inter-
action being highly dynamic. Just a few examples: high-mobility
group box 1 (P09429) and coﬁlin (P23528) are strongly upregu-
lated 4 h p.i., return to “normal” 4 and 16 h later, while at 7–10
days p.i. both are downregulated; glucose-6-phosphate isomerase
(P06744) is upregulated at 8 h p.i., but at 7–10 days p.i. is found
to be downregulated.
Given all this complexity, it is safe to say that proteomic studies
on HIV-1 in general, and on HIV–T cell interaction in particu-
lar, will continue to generate new insights. But it will not be easy
to translate these snapshot datasets into a comprehensive mecha-
nistic understanding of all interactions involved (Haarburger and
Pillay, 2010; Zhang et al., 2010). As mentioned, another problem
of proteomic studies is identiﬁcation and quantiﬁcation of pro-
teins with lower abundancies. One of the possible solutions to do
this in a relatively unbiased fashion is sampling a proteome via
interaction with random hexameric peptides using Arg, Lys, His,
Phe, Tyr, Trp, Leu, andVal only: proteominer beads (Boschetti and
Righetti, 2008). Samples still seem to be dominated by the most
abundant proteins, however. “Looking at less to see more” might
be the better way ahead. Such focusing could be on the analysis of
speciﬁc cellular fractions (e.g. mitochondrial preparations), or on
the selective study of speciﬁc classes of protein or PTMs, such as
the phosphoproteome mentioned above.
Another example of zooming in on speciﬁc protein subsets
is the use of methods to enrich for cellular factors that directly
interact with HIV-1 proteins. Exciting results have been obtained
with such “interactome proteomics” methods. The most general
approach was performed with tagged versions of all 18 HIV-1
(poly)proteins. The accessory factors Vif, Vpu, Vpr, and Nef,
Tat and Rev, as well as the polyproteins Gag, Pol, and Gp160,
and their processed products (MA, CA, NC, and p6; PR, RT,
and IN; Gp120 and Gp41, respectively) were used as bait. Inter-
acting proteins were subjected to proteomic analysis by tryptic
digestion followed by LC–MS/MS, again using an Orbitrap (Jager
et al., 2012a). Interactomics for individual HIV-1 proteins have
also been reported. Vif interactomics revealed how Vif targets the
antiviral APOBEC3G protein for degradation via CBF-β, using
the method just described (Jager et al., 2012a,b). The Rev pro-
tein was used as bait to ﬁsh for partners in HeLa cell extracts,
which were then analyzed by MudPIT (Multidimensional Protein
Identiﬁcation Technology) LC–MS/MS (Naji et al., 2012). “Indi-
rect” interactomics has also been performed by expressing either
wild-type Vpu or Vpu that is unable to associate with F-box pro-
tein β-TrCP in HeLa cells. Without this interaction Vpu cannot
target certain cellular proteins for degradation by the protea-
some. Potential targets of Vpu were then identiﬁed by quantitative
proteomics using SILAC (stable isotope labeling by amino acids
in cell culture) followed by LC–MS/MS (Douglas et al., 2009).
Much attention has been focused on the multiple roles of the CA
(capsid) protein (Mascarenhas andMusier-Forsyth, 2009) and the
Tat protein (Sobhian et al., 2010).
In many cases results of proteomic studies were compared
with the results of stable RNAi-knockdown experiments. Global
approaches to identify host cofactors usually consist of screen-
ing for reduced viral replication upon RNAi knockdown, or
enhanced replication in case a cellular restriction factor is hit
(Zhou et al., 2008; An and Winkler, 2010). Such genome wide
RNAi screens can easily lead to both false positives (by off-target
effects) and false negatives (by inefﬁcient knockdown). These con-
siderations emphasize the importance of performing a concerted
multi-disciplinary experimental approach, including gene expres-
sion (transcriptome analysis), RNAi and proteomic studies using
different detection and labeling techniques. At the same time, such
a wider survey will generate more and larger datasets in formats
which are not at all easily compared: an enormous future challenge
for bioinformaticians. In light of this we also stress the importance
of speciﬁc, non “omic,” hypothesis driven follow-up research: not
generating large new datasets but asking highly speciﬁc questions.
The answers might just make integrating these large datasets a
lot easier.
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